key: cord-1003883-a9kap12m
authors: Chung, Chen-Shuan; Tsai, I-Fang; Lee, I-Hua; Tsai, Pei-Chun; Wu, Mei-Yu; Huang, Ya-Ching; Ma, Jing-Yi; Tseng, Po-Chun; Chiu, Kuan-Ming; Liao, Chun-Hsing
title: Preventive strategy of gastrointestinal endoscopy unit against COVID-19: A tertiary center experience in Taiwan
date: 2021-04-30
journal: J Microbiol Immunol Infect
DOI: 10.1016/j.jmii.2021.04.003
sha: a5b57855df74351f9d99ca2dce5ab17e4f7a97d5
doc_id: 1003883
cord_uid: a9kap12m

nan

Preventive strategy of gastrointestinal endoscopy unit against COVID-19: A tertiary center experience in Taiwan Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become global pandemic since the early 2020. 1e3 It is spread out by aerosol droplet, saliva and feces whereas gastrointestinal (GI) endoscopy poses a potential risk for transmission. 1e4 We took countermeasure to prevent GI endoscopy associated COVID-19 infection since late January 2020 at the Ultrasonography and Endoscopy Center of Far Eastern Memorial Hospital in Taiwan.

All personnel entering the hospital had to wear surgical masks, including staffs, patients and accompanying persons. They used smart phone to self-report a 7-day renewed TOCC questionnaire. A checkpoint station was set up at the entry of hospital and endoscopy unit. Risk stratification for possible COVID-19 exposure were done by checking body temperature, reading TOCC data and health ID card which linked to immigration record. Social distancing was executed with at 1.5-m distance marking at floor in the queue area and chairs in the waiting zone, and cleanable plastic clapboard in catering area for separation of staffs. There were dedicated endoscopes, processors, automatic endoscope reprocessors, and disinfection and storage areas for confirmed COVID-19 infected patients.

Low risk patients received endoscopy in regular rooms, and high risk or confirmed patients in negative-pressure rooms. Donning and doffing personal protection equipment (PPE) was performed as recommended orders. For patients at high risk or confirmed infection, all endoscopes and processors were protected with disposable transparent plastic film, and an acrylic box at patient's head position to prevent staffs from saliva and aerosol droplets exposure ( Fig. 1 ). Alternative percutaneous biliary drainage was recommended for obstructive jaundice patients at high risk for COVID-19 instead of duodenoscopy. Elective colonoscopy for diarrhea patients with positive TOCC within 2 weeks was postponed.

Patients were scheduled back to outpatient department within 14 days to inquire about new-onset COVID-19 related symptoms. All endoscopy accessories were disposable and processed as contaminated wastes. Staffs who had been exposed to high risk or confirmed patients strictly followed autonomous health management and reported back if any suspicious symptoms. All endoscopes used in high-risk or confirmed patients underwent routine high-level disinfection with detergent-immersion method which prevents aerosol particle spilled out. Terminal disinfection of the environment in the endoscopy suite with 75% alcohol and 600 ppm sodium hypochlorite were performed.

Until 4th April 2021, the global data showed more than one hundred and thirty million confirmed cases with about 2.8 million deaths (mortality rate 2,848,304/130,893,813 Z 2.2%) in 192 countries. 2 In Taiwan, there were 1047 confirmed patients with 10 deaths (mortality rate 1.0%). In our institute, totally 14,119 persons received RT-PCR for SARS-CoV-2 until February with 10 confirmed cases without mortality. Between 1st January 2020 and 24th February 2021, there were 22,294 patients underwent endoscopic procedures and 8060 accompanying persons with real-name registered. 420 suspicious but PCR tested negative patients underwent endoscopic examination. There was no GI endoscopy related SARS-CoV-2 transmission in our institute.

Preventive strategy against COVID-19 by reallocation of endoscopy or institute resources and risk stratification is crucial to decrease the spread of SARS-CoV-2 before effective treatment and vaccine developed. 5e7 

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status

COVID-19 dashboard by the Center for Systems Science and Engineering

Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019: a systematic review and meta-analysis

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths

Triaging advanced GI endoscopy procedures during the COVID-19 Pandemic: consensus recommendations using the Delphi method

Safely restarting GI endoscopy in the era of COVID-19

How to prevent outbreak of a hospital-affiliated dementia daycare facility in the pandemic COVID-19 infection in Taiwan

The authors have no conflicts of interest or financial ties to disclose.